Healthy VolunteersPersonality & Trait FactorsDMT

Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers

This subgroup reanalysis of a RCT (n=28) in healthy men found that a combined DMT and harmine formulation reduced embarrassment and shame when participants evaluated their own singing, whereas harmine alone did not. The effect was seen only for self-related negative emotions and not for other vocal recordings.

1 linked clinical trial·34 references indexed in Blossom

Authors

  • Helena Aicher
  • Milan Scheidegger
  • Dominik Dornbierer

Published

Psychopharmacology
individual Study

Abstract

Rationale and objectives

Negative self-referential emotions such as embarrassment and shame play a key role in the psychopathology of psychiatric disorders but are often insufficiently addressed by standard treatments. Psychedelics such as ayahuasca – an Amazonian plant decoction containing the psychedelic N,N-dimethyltryptamine (DMT) and harmala alkaloids, have been proposed to positively modulate self-referential processing. The aim of this study was to investigate the effects of an ayahuasca-inspired harmine+DMT formulation and harmine on embarrassment and shame.

Methods

In this randomized, double-blind, placebo-controlled crossover trial (N = 28 healthy males), the effects of combined 100mg harmine and 100mg DMT (HAR/DMT), harmine alone (HAR), against placebo (PLA) on self-referential processing was investigated using a karaoke paradigm, where participants listened to recordings of their own singing (Self = S) and control vocal tracks (other bad = OB; other good = OG) and rated emotional responses. Acute emotions were assessed with visual analogue scales (items: pleasant, unpleasant, embarrassing, funny, and objective quality) and the Experiential Shame Scale (ESS).

Results

HAR/DMT compared to placebo significantly reduced embarrassment in the Self condition (EMM=-16.83, p=.001), but not in the two other conditions (OB: EMM=-4.38, p=.628; OG: EMM= 2.14, p=.894). HAR/DMT–HAR or HAR–PLA contrasts for embarrassment were not significant for any condition. HAR/DMT compared to placebo reduced ESS global score (F(df)= 4.26(2, 54); p=.019) and ESS emotional subscale (F(df)=5.11(2, 54); p=.009), while harmine alone showed no significant effects.

Conclusions

These findings suggest that HAR/DMT acutely modulates negative self-referential emotions and may, thus, offer a promising therapeutic approach, which should be further investigated in clinical populations.

Unlocked with Blossom Pro

Research Summary of 'Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers'

Editorial

βBlossom's Take

This paper is useful because it tests a very specific social emotion, shame, in a controlled task rather than relying on broad mood ratings. The selective effect for self-related negative feelings, with harmine alone inactive, makes it a neat piece of evidence that combined DMT and harmine may alter self-evaluation in a more targeted way than general emotional arousal.

Introduction

Negative self-referential emotions such as embarrassment and shame are important features of several psychiatric disorders, including depression, social anxiety and trauma-related conditions, but existing treatments do not specifically target these processes well. The paper frames psychedelics, especially ayahuasca-related compounds, as potentially useful because they may alter rigid self-focused processing, increase self-compassion and reduce maladaptive self-criticism. The authors note that although earlier work suggests psychedelic effects on social cognition, emotional empathy and self-referential processing, it remains unclear whether these compounds can acutely reduce embarrassment and shame in a controlled, socially evaluative setting. Aicher and colleagues therefore aimed to test whether an ayahuasca-inspired formulation containing harmine and DMT would reduce negative self-referential emotions during a karaoke-based social self-evaluation task, and whether harmine alone would have similar effects. They hypothesised that HAR/DMT, but not harmine alone, would reduce embarrassment and shame relative to placebo, particularly when participants heard recordings of their own singing. The study was presented as part of a broader investigation of self-referential processing in the same sample.

Methods

The researchers conducted a randomised, double-blind, placebo-controlled crossover trial in healthy adult men. Although 36 volunteers were recruited, five withdrew and three were excluded because of technical recording problems, leaving 28 participants in the analysed sample. Participants were 20-40 years old, right-handed, fluent in German, with normal hearing, BMI between 18.5 and 30, minimal psychedelic experience, and no current or past psychiatric or neurological disorders. Female participants were excluded because of concerns about hormonal influences on endocrine and emotional measures. Each participant completed three intervention days separated by at least two weeks. Using a Latin square design, they received HAR/DMT, harmine alone, and placebo in randomised order. Randomisation was computer-generated by an independent researcher, and blinding was maintained with identical opaque containers and matched placebos. Harmine was given as a 100 mg orodispersible tablet for buccal delivery. DMT was delivered intranasally in repeated 10 mg increments to reach 100 mg in total, starting 30 minutes after harmine premedication; two 10 mg doses were skipped in the HAR/DMT condition because of strong acute effects, resulting in a 90 mg cumulative DMT dose in those instances. Participants were monitored throughout the day, with drug and alcohol screening, breakfast, baseline ratings, safety checks and blood sampling. The main behavioural task was an adapted karaoke paradigm designed to induce social self-evaluation. Participants selected songs, recorded their own singing, and later listened to three stimulus types: their own singing (Self), a confederate version (Other Bad) and original artist recordings (Other Good). After each stimulus sequence, they rated pleasantness, unpleasantness, embarrassment, funniness and perceived objective quality on visual analogue scales. After completing the task, they also completed the German version of the Experiential Shame Scale, which assessed state shame across emotional, physical and social subscales. Data were analysed in R using mixed-model ANOVA with drug condition and karaoke category as factors for the visual analogue scale outcomes, and drug condition for the Experiential Shame Scale outcomes. Pairwise contrasts were adjusted using the Tukey method, degrees of freedom were estimated with the Kenward-Roger method, and the significance threshold was p=0.05. Planned simple-effects contrasts comparing HAR/DMT, harmine and placebo were reported regardless of the omnibus interaction.

Results

The karaoke task reliably elicited different emotional responses across stimulus types. There was a strong main effect of karaoke condition on all visual analogue scale ratings, including pleasantness, embarrassment, funniness, unpleasantness and objective quality, with all p-values below .001. There was also a significant main effect of drug condition for unpleasantness and objective quality, but not for pleasantness, embarrassment or funniness. The interaction between drug condition and karaoke category was significant for pleasantness and unpleasantness, but not for embarrassment, funniness or objective quality. For the main shame measure, the Experiential Shame Scale, drug condition significantly affected the global score and the emotional subscale, but not the physical or social subscales. The paper reports that HAR/DMT, compared with placebo, significantly reduced embarrassment in the Self condition, with an estimated marginal mean difference of -16.83 and p=.001. This effect was not present for the Other Bad or Other Good conditions. HAR/DMT versus harmine, and harmine versus placebo, did not significantly differ for embarrassment in any condition. In addition, HAR/DMT reduced the Experiential Shame Scale global score (F=4.26, p=.019) and emotional subscale (F=5.11, p=.009), while the physical and social subscales were not significant. Harmine alone did not show significant effects on the shame scale. The authors also note that HAR/DMT increased pleasantness and lowered unpleasantness in some comparisons, and that perceived objective quality of singing was rated more favourably under the active condition across all stimulus types. They report that funniness ratings were unchanged, which they interpret as suggesting that the findings were not simply due to nonspecific mood elevation or emotional detachment.

Discussion

The authors interpret the findings as evidence that the combined harmine and DMT formulation can acutely reduce negative self-referential emotions in a socially evaluative context. They argue that the karaoke task successfully induced embarrassment and shame in response to hearing one’s own singing, and that HAR/DMT specifically reduced self-related unpleasantness, embarrassment and the emotional aspects of shame compared with placebo, whereas harmine alone did not produce the same pattern. They also emphasise that unchanged funniness ratings argue against a simple explanation based on general mood elevation. Aicher and colleagues compare their findings with earlier research showing that psychedelics can alter social cognition, increase emotional empathy and prosociality, and reduce negative affective bias. They suggest that the observed effects may reflect a broader shift towards more positive social processing, possibly involving reduced threat perception, decentering, self-compassion and altered self-other differentiation. They also discuss the possibility that changes in perceived singing quality may indicate a general positivity bias or altered auditory/aesthetic perception, although they argue that this does not fully explain the selective reduction in embarrassment. The authors consider the pattern of results on the shame scale to indicate that HAR/DMT may mainly reduce the internal emotional distress of shame rather than its social or bodily components, although they acknowledge alternative explanations such as altered embodiment or interoception. They also describe harmine as showing an intermediate, subtle pattern in some measures, but not a robust independent effect. Neurobiologically, they propose that modulation of the default mode network and related self-referential circuitry could underlie the behavioural effects, though this was not directly measured in the study. The main limitations they acknowledge are the exclusively healthy male sample, which restricts generalisability; possible expectancy effects and incomplete blinding; the retrospective administration of the shame scale after the full task; the lack of a formal blinding check and objective biomarkers; the absence of a prospectively powered analysis plan specific to this outcome; and the fact that the karaoke paradigm has not been formally validated against standard social-stress tasks. They also note the possibility of residual carryover or habituation effects despite the crossover and Latin square design. Clinically, they suggest that acute modulation of negative self-referential affect may be relevant to depression, social anxiety and trauma-related conditions, and that the formulation could potentially complement therapies such as Compassion-Focused Therapy or Acceptance and Commitment Therapy, although they stress that structured support and careful ethical consideration would be necessary.

Conclusion

The authors conclude that HAR/DMT reduced negative self-referential emotion in a controlled social-evaluative setting. They suggest that the paradigm may be useful for probing broader self-referential emotions such as self-consciousness, pride and self-compassion, and they present HAR/DMT as a promising tool for studying and potentially addressing maladaptive self-referential processing. They state that further studies in clinical populations are needed.

Expert Research Summary

Go Pro to unlock section-by-section summaries, Blossom's editorial take, and the complete research toolkit.

See Pro Plans
View full paper sections

PARTICIPANTS AND PERMISSIONS

Thirty-six healthy right-handed male volunteers (aged 20-40 years; M = 24.79, SD = 3.89) were recruited. Female participants were excluded due to potential hormonal influences on endocrine and emotional outcome measures examined during this study. Inclusion criteria were fluency in German, normal hearing, body mass index (BMI) between 18.5 and 30, and minimal psychedelic experience (≤ 15 lifetime uses). Exclusion criteria included current or past psychiatric or neurological disorders, regular substance use (self-report), a family history of Axis-I psychiatric disorders, professional singing ability, or absolute pitch. Participants provided written informed consent. The study was approved by the Cantonal Ethics Committee Zurich (BASEC-Nr. 2018 -01385) and the Swiss Federal Office of Public Health (BAG-Nr. (AB)-8/5-BetmG-2019/008014) and was conducted in accordance with the Declaration of Helsinki. The trial was preregistered on ClinicalTrials.gov (NCT04716335). Five participants withdrew from the study due to personal reasons or inability to adhere to cannabis use abstinence. Three participants were excluded from analysis due to technical recording issues. The final sample included 28 participants (mean age = 24.79 years, range = 20-37, SD = 3.89). Twelve participants had no prior psychedelic exposure, while the remaining 16 reported minimal use of psychedelic substances, including LSD, psilocybin, ayahuasca or DMT, 4-bromo-2,5-dimethoxyphenethylamine (2 C-B), or mescaline. Full demographic and substance use history is reported elsewhere.

STUDY DESIGN AND PROCEDURE

The study followed a randomized, double-blind, placebocontrolled crossover design with three intervention days, each separated by a wash-out period of at least two weeks to minimize carryover effects. A Latin square design was used to counterbalance the treatment order across participants. Each participant received the following interventions in randomized order: HAR/DMT: harmine+DMT; HAR: harmine+placebo; PLA: placebo+placebo. Randomization was computer-generated by an independent researcher. Blinding was maintained using identical opaque containers and matched placebo formulations. Participants underwent a telephone screening including information about study procedures and inclusion and exclusion criteria. If interested, participants provided informed consent and underwent a medical screening to assess inclusion and exclusion criteria. After inclusion, voice recording for the karaoke task was performed. After that, participants were invited for three study intervention days. On each intervention day, participants arrived in the morning, drug and alcohol screening were performed, a standardized breakfast was provided, baseline visual analogue scale (VAS) ratings and psychometric questionnaires were completed, and then participants remained in a comfortable room with dim lighting and ambient music throughout the day. Safety monitoring (heart rate, blood pressure, and subjective state assessments) and blood sample withdrawal was conducted throughout the session. An overview of the study design and experimental procedure is provided in Fig..

STUDY DRUG AND ADMINISTRATION

Participants received HAR/DMT, HAR, or PLA in a doubleblind, randomized, placebo-controlled design. Harmine was administered as an orodispersible tablet (ODT) for buccal delivery, while DMT was formulated as an intranasal spray solution. This administration method enabled incremental dosing of DMT, ensuring standardized bioavailability; the dose and titration schedule were selected based on this previous dose-finding study, which identified repeated-intermittent intranasal DMT combined with buccal harmine as producing consistent pharmacokinetic profiles with good tolerability. Pharmacokinetic and pharmacodynamic parameters of this formulation in the present sample are reported in. Thirty minutes after premedication with harmine (100 mg) or a matching placebo, repeated intermittent dosing of DMT or placebo commenced. A total of 100 mg DMT was administered intranasally in ten increments (10 mg per dose), spaced 15 min apart (except for one interval of 30 min due to a behavioral task). Participants were allowed to skip individual DMT administrations in the event of tolerability issues, with the option to resume dosing at the next time point. This skip option was used only twice during the study. The two instances of dose skipping (one dosing increment of 10 mg DMT each) occurred in the HAR/DMT condition due to strong drug effects, resulting in a cumulative dose of 90 mg DMT, and confirm pharmacological responsiveness in these participants.

KARAOKE TASK

The karaoke task was adapted from, who developed the task to induce emotional distress. A list of 16 well-known songs was preselected based on criteria such as popularity, male vocals, and suitable chorus content. Participants selected four songs from this list to sing karaoke-style. Audio-recordings were made of each participant's performances (for the Self condition = S), as well as standardized versions by a confederate (for the Other Bad condition = OB), and vocal-only tracks from the original artists (for the Other Good condition = OG). Participants wore headphones to mask auditory feedback from their own voice, limiting their ability to correct potential off-pitch in real time. From each song, three 16-second vocal excerpts were extracted from the self-performance, confederate version, and original artist recording. These matched segments were combined into a single task version for each study session, such that participants heard identical song segments under the three conditions S, OB, and OG. Full stimulus preparation procedures and audio processing details are described in Supplementary B. The task stimuli were presented in E-Prime 3.0 (Psychology Software Tools, Inc., 2016) with 12 sequences per session (4 per condition), randomized to prevent repeated sequence types. After each sequence, participants rated the VAS-items pleasant, unpleasant, embarrassing, funny, and objective quality. A short 1-back cognitive task was presented between trials to mitigate emotional carryover by redirecting attentional Fig.Overview of the overall study design and experimental procedure of study intervention days. Note. (A) The overall study design included a telephone screening (visit 0), followed by a medical screening on site (visit 1). After inclusion, a voice recording for the karaoke task was performed (visit 1). Drug intervention and task performance took place at visits 2-4. (B) Intervention days included randomized, double-blind, crossover drug administration (HAR/DMT, HAR, PLA) and performance of the karaoke task included voice presentation resources away from the preceding emotional stimulus, based on the principle that cognitive engagement can interrupt emotional processing. Participants proceeded at their own pace, and each 1-back task lasted 20 s. After completion of the task, state shame was assessed using the German version of the ESS), an 11-item instrument assessing affective, physiological, and social facets of state shame. Responses were provided on a 7-point Likert scale specifically referencing participants' reactions to hearing their own singing, although the retrospective nature of this assessment (completed after exposure to all stimulus categories) means that recall may have been influenced by the intervening stimuli. The karaoke task design and procedure are visualized in Fig.. Further information on the task can be found in the Supplementary Materials.

STATISTICAL ANALYSIS

The data were analyzed with R Studio version 2021.09.2 + 382. A Mixed Model ANOVA (Type 3 S-method) was calculated with drug condition (HAR/DMT, HAR, PLA) and karaoke category (S, OG, OB) as independent variables, and the VAS items as dependent variables using the r-package afex). The same model was used to assess differences in the ESS, with drug condition (HAR/DMT, HAR, PLA) as an independent variable and the ESS global score and subscales as dependent variables. Pairwise contrasts were calculated using the r-package emmeans) using the Tukey method for comparing a family of three estimates (p-value adjustment). Simple-effects contrasts comparing HAR/DMT, HAR, and PLA conditions were planned a priori based on our theoretical hypotheses and are reported regardless of the omnibus interaction term. Degrees of freedom (Df) were calculated using the Kenward-Roger method. The significance level was set to p=.05.

DRUG AND CATEGORY EFFECTS ON EMOTIONAL AND SELFEVALUATIVE RATINGS

The Mixed Model ANOVA revealed a significant main effect of the karaoke condition on all VAS items (pleasant: F(df) = 170.18; p<.001; embarrassing: F(df) = 86.32, p<.001; funny: F(df) = 92.20, p<.001; unpleasant: F(df) = 138.43, p<.001; objective quality: F(df) = 366.09, p<.001). The main effect of the drug condition was significant for unpleasant (F(df) = 10.77; p<.001) and objective quality (F(df) = 4.71; but not for pleasant (F(df) = 2.96; p=.054), embarrassing (F(df) = 2.92; p=.054), and funny (F(df) = 0.15; p=.862). The interaction effect between karaoke condition and drug condition was significant for pleasant (F(df) = 3.44; p=.009) and unpleasant (F(df) = 3.75; but not for embarrassing (F(df) = 2.18, funny (F(df) = 0.90, and objective quality (F(df) = 1.72. Planned simple-effects contrasts were conducted within each karaoke condition (S, OB, OG) to examine drug-related differences, with Tukeyadjusted p-values applied within each outcome. Results are visualized in Fig.. Supplementary Tableshows results for all VAS outcome variables (pleasant, embarrassing, funny, unpleasant, quality), including pairwise contrasts for main effects of drug and stimulus category, as well as interaction effects between drug condition and category.

EXPERIENTIAL SHAME SCALE

The Mixed Model ANOVA revealed a significant effect of the drug condition on the ESS global score (F(df) = 4.26; p=.019) and on the ESS emotional subscale (F(df) = 5.11; p=.009), but no significant effects on the ESS physical subscale (F(df) = 2.42; p=.098) nor on the ESS social subscale (F(df) = 0.33; p=.717). Tablepresents pairwise contrasts for the main effect of drug condition on the ESS global score and subscales, collapsed across stimulus category. Results are visualized in Fig..

DISCUSSION

This randomized, double-blind, placebo-controlled crossover trial demonstrated that combined harmine and DMT (HAR/DMT) can acutely reduce negative self-referential emotions. The trial used a karaoke-based task to induce selfreferential emotional responses in real time. Participants listened to playback of heir own singing in direct comparison to another layperson's performance and the original professional recording in the presence of study personnel, thereby creating a socially evaluative context, which reliably elicited negative self-referential emotions. In the self-related condition (playback of one's own singing), reductions in ratings of unpleasant and embarrassing, as well as in emotional components of shame as measured by the ESS, and an increase for the rating of pleasant were observed in the HAR/DMT condition compared to PLA but not compared to HAR alone. In contrast, no effects were observed for VAS ratings of funny, suggesting that the observed changes in self-referential emotions were unlikely to reflect nonspecific mood elevation or emotional detachment. On the other hand, participants also rated their own singing objective quality more favorably under the active condition across all stimulus types, which might suggest that the reduced negative self-referential emotions could, at least in part, be confounded by an altered perception or evaluation of auditory stimuli, or a general positivity-bias, rather than a modulation of specifically self-referential emotional reactivity. Previous challenge studies have consistently demonstrated that serotonergic psychedelics robustly modulate social cognition by enhancing emotional empathy and prosociality, while impairing the recognition of negative affective cues, such as fear and sadness. Neurobiologically, this dampened sensitivity to social threat is thought to be mediated by 5-HT2A receptor-dependent reductions in amygdala reactivity. In the socially evaluative context of our karaoke paradigm, this general shift towards positive social processing might diminishes the perceived threat of negative judgment from observers, thereby potentially reducing the foundation for embarrassment. However, a closer inspection of the interaction effects on quality ratings is informative. The quality elevation under HAR/DMT was significant in the OB condition (vs. HAR: p=.018; vs. PLA: p=.039) but only a trend in the Self condition (vs. HAR: p=.038; vs. PLA: p=.109), with no effects in the OG condition. If the embarrassment reduction were primarily driven by participants perceiving their own singing as objectively better, the quality effect would be expected to be strongest in the Self condition -which the data do not support. This pattern suggests a more general shift in auditory or aesthetic perception rather than a targeted self-serving bias, and therefore does not straightforwardly account for the selective reduction in embarrassment. Future studies should aim to disentangle perceptual changes from core affective shifts in self-referential processing. The selective reduction in emotional but not social or physical components of shame on the ESS might suggest that HAR/DMT primarily attenuated the internal affective distress of shame, without altering participants' awareness of others' judgment or their bodily shame responses. However, it might also be explained by a potential reduction in bodily awareness or disembodiment, often experienced under psychedelic interventions, or by a reduction in the perception of social judgement, potentially related to alterations in social exclusion processing. Interestingly, there was a non-significant trend towards higher scores on the physical subscale under HAR/DMT (p=.098), which may reflect pharmacologically induced autonomic arousal or increased bodily awareness and interoception under HAR/DMT, rather than shamerelated physical responses per se. However, given the absence of a significant effect, this pattern should be interpreted with caution and may simply reflect noise. Interestingly, although the subjective effects of HAR alone have generally been reported as indistinguishable from placebo, the present findings suggest that HAR may induce a subtle intermediate pattern on selfreferential emotions during the karaoke task. No significant differences between HAR/DMT and HAR were observed in embarrassing ratings, and likewise no significant differences emerged between HAR and PLA for unpleasant, embarrassing, or pleasant, positioning the effects of HAR effects descriptively between HAR/DMT and PLA. These results align with our previous findings, where HAR affected only self-compassion but no broader subjective measures. Taken together, this pattern suggests that the effects of HAR alone may slightly influence selfreferential processing without substantially altering overall aspects of the subjective experience. The results of our study converge with prior research showing that psychedelics can decrease self-blame and facilitate more adaptive forms of self-appraisal. One mechanism potentially contributing to these effects is decentering, a facet of mindfulness, which refers to the capacity to observe thoughts and emotions as transient rather than identifying with them. Decentering has been shown to be increased by administration of ayahuasca) and also HAR/DMT in a mindfulness retreat setting (Meling ). This shift in perspective is a common feature of psychedelic experiences, and can be conceptually linked to the substance-induced enhancement of empathy mentioned above. When empathy is directed inward from a decentered perspective, it mirrors the psychological phenomenon known as the "beautiful mess effect". In normal states of consciousness, individuals exhibit a pronounced self-other differentiation, judging their own social missteps (like a poor singing performance) negatively, while perceiving the same vulnerability in others as authentic or endearing. By promoting decentering and enhancing emotional empathy, the HAR/ DMT formulation may bridge this self-other gap, allowing individuals to adopt an observer's benevolent perspective on their own social vulnerability. The broader emotional profile under HAR/DMT is consistent with transient increases in self-compassion, which have been observed following ayahuasca administration, but also with HAR/DMT itself. These findings, obtained from the same participants within the same study, are best understood as complementary and mutually reinforcing rather than independent. Both self-compassion and embarrassment/shame are latent constructs and therefore can only be inferred from specific measures, each capturing a different facet of the same broader shift in self-referential processing. Increased self-compassionwill likely be associated with decreased embarrassment in the social-evaluative karaoke context, and vice versareduced embarrassment in social situations may itself be a behavioral expression of increased self-compassion. The convergence of these findings across a subjective questionnaire measure and a social task paradigm thus strengthens the overall conclusion that HAR/DMT broadly modulates how individuals relate to themselves. Furthermore, this convergence across complementary levels of measurement, obtained from the same participants within the same study, provides indirect support for the construct validity of the karaoke paradigm, suggesting that it likely captures a conceptually related shift in self-referential processing that is reflected in these other measures. While not directly assessed here, the pattern of VAS and ESS outcomes supports this mechanistic hypothesis. Building on these psychological mechanisms, neurobiologically, these effects may be driven by a modulation of the DMN, consistent with recent evidence showing attenuated selfother neural differentiation under a HAR/DMT formulation, derived from the same sample. While we didn't directly measure brain network dynamics here, previous studies have shown a modulation of the DMN by psychedelics. This mechanism could explain the disruption of habitual self-focus and rumination -which are characteristic for depression -and thereby the reductions in negative self-referential processing.

CLINICAL IMPLICATIONS

The present findings suggest that acute modulation of negative self-referential affect by HAR/DMT may be clinically relevant for disorders characterized by shame, self-criticism, and maladaptive self-focus, including depression, social anxiety, and trauma-related conditions. However, it should be noted that the present sample consisted exclusively of healthy male participants, whereas depression, PTSD, and social anxiety disorder disproportionately affect women. The degree to which these findings generalize to female or mixed-sex clinical populations remains to be established. The short duration and good tolerability profile of the formulation) may allow for flexible integration into therapeutic settings where time constraints are a factor, though whether such brief formats support the emotional depth and integration essential to psychedelic therapy remains an open question. Integrating HAR/DMT with established psychotherapeutic approaches targeting experiential avoidance and psychological flexibility, such as Compassion-Focused Therapy or Acceptance and Commitment Therapy, may represent a theoretically coherent framework in which psychedelics function as pharmacological augmenters of these processes. Given the vulnerability inherent in self-referential emotional processing, clinical translation of such interventions requires structured therapeutic support and careful ethical considerations.

LIMITATIONS

Although the selective reduction in negative self-referential emotions points to a targeted pharmacological effect, we cannot fully exclude the possibility that participants' expectations influenced their self-reports due to blinding issues). However, the stable funny ratings and lack of significant changes in the social and physical subscales of the ESS suggest that participants' responses were not, or at least not fully, driven by expectancy. Furthermore, the inclusion of the HAR condition may have helped to reduce unblinding by making condition discrimination potentially less straightforward. Future studies should include a formal blinding check, potentially further active placebo conditions, and objective biomarkers to better distinguish pharmacological effects from expectancydriven responses). As mentioned above, objective quality ratings were higher in the HAR/DMT condition, potentially indicating a general positivity bias, which might have influenced participants' response. A limitation regarding the EES is that it was administered retrospectively after completion of the full karaoke task. Although participants were explicitly instructed to reference their reactions to hearing their own singing, retrospective recall may have been influenced by the intervening OB and OG stimuli. Future studies would benefit from administering the ESS immediately after each Self condition trial to obtain more temporally precise shame assessments. Furthermore, the inclusion of only healthy male participants limits generalizability, especially given sex-specific differences in emotional processing and psychedelic effects, and considering that depression, PTSD, and social anxiety have a higher prevalence in women. Although participants were required to have no more than 15 lifetime uses of psychedelics, and nearly half were psychedelicnaïve, prior exposure may still have influenced expectancy effects, which future studies should account for more systematically. A further limitation concerns the sample size: A formal a priori power calculation specific to the karaoke paradigm outcome was not conducted, as the sample size was determined based on the broader study protocol and justified to the institutional review board on the basis of experience from previous studies quantifying the effects of 5-HT2A receptor agonism in within-subject designs. Although the karaoke paradigm was included as a preregistered outcome measure, no formal statistical analysis plan was prespecified in the trial registration. The analytical approach reported here was therefore not preregistered, and the findings should be interpreted with appropriate caution pending replication in a prospectively powered study with a prespecified analysis plan. Another limitation concerns the karaoke task: While the karaoke task elicited reliable emotional responses, it has not yet been formally validated against standardized measures of social-evaluative stress, such as the Trier Social Stress Test, which reliably induces emotional and physiological reactivity through direct social judgment. Although a cognitive 1-back task was included to reduce emotional carryover between trials, future research should further control for task repetition or habituation effects, which may arise across multiple sessions. Although a Latin square design was used to counterbalance treatment order across participants -which should control for potential systematic order and habituation effects by distributing them evenly across drug conditions -we cannot fully exclude residual carryover or habituation effects. Furthermore, incorporating hormonal, psychophysiological, and neural data in future studies would strengthen mechanistic interpretations. Replication in more diverse samples and cultural contexts will be essential to determine the generalizability and boundary conditions of these effects. Finally, as the findings reported here are one component of a larger multi-outcome study, they should be read alongside companion publications from the same sampleto fully appreciate the convergent, multi-level profile of HAR/DMT effects on self-referential processing.

CONCLUSION

In summary, HAR/DMT reduced negative self-referential emotion in a controlled social-evaluative context. While this study focused primarily on embarrassment and shame, the paradigm may be useful for probing a broader range of self-referential emotions, such as self-consciousness, pride, or self-compassion. The findings position HAR/DMT as a promising tool for both investigating and therapeutically addressing maladaptive self-referential processing. Further studies in clinical patient populations with conditions characterized by maladaptive self-referential processing are needed.

Full Paper Sections

Go Pro to read the extracted full-text sections.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

References (34)

References cited by this study and indexed in Blossom.

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

Aicher, H. D., Mueller, M. J., Dornbierer, D. A. et al. · Frontiers in Psychiatry (2024)

31 cited
Serotonergic psychedelics and personality: A systematic review of contemporary research

Bouso, J. C., Dos Santos, R. G., Hallak, J. E. · Neuroscience and Biobehavioral Reviews (2018)

133 cited
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)

1520 cited
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety

Davis, A. K., Barrett, F. S., Griffiths, R. R. · Journal of Contextual Behavioral Science (2020)

367 cited
LSD acutely impairs fear recognition and enhances emotional empathy and sociality

Dolder, P. C., Schmid, Y., Müller, F. et al. · Neuropsychopharmacology (2016)

246 cited
Ayahuasca may help to improve self-compassion and self-criticism capacities

Domínguez-Clavé, E., Soler, J., Elices, M. et al. · Human Psychopharmacology (2021)

29 cited
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder

Doss, M. K., Považan, M., Rosenberg, M. D. et al. · Translational Psychiatry (2021)

335 cited
Show all 34 references
Default Mode Network Modulation by Psychedelics: A Systematic Review

Gattuso, J. J., Perkins, D., Ruffell, S. G. D. et al. · International Journal of Neuropsychopharmacology (2022)

219 cited
Neuropharmacological modulation of the aberrant bodily self through psychedelics

Ho, J. T., Preller, K. H., Lenggenhager, B. · Neuroscience and Biobehavioral Reviews (2020)

59 cited
Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers

Kraehenmann, R., Preller, K. H., Scheidegger, M. et al. · Biological Psychiatry (2015)

320 cited
Psychedelics promote structural and functional neural plasticity

Ly, C., Greb, A. C., Cameron, L. P. et al. · Cell Reports (2018)

1134 cited
Cortical structural differences following repeated ayahuasca use hold molecular signatures

Mallaroni, P., Mason, N. L., Kloft, L. et al. · Frontiers in Neuroscience (2023)

7 cited
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat

Meling, D., Egger, K., Aicher, H. D. et al. · Journal of Psychopharmacology (2024)

14 cited
8 cited
Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials

Muthukumaraswamy, S., Forsyth, B., Lumley, T. · Expert Review of Clinical Pharmacology (2021)

14 cited
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network

Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)

458 cited
26 cited
Psilocybin-Assisted Compassion Focused Therapy for Depression

Pots, W., Chakhssi, F. · Frontiers in Psychology (2022)

29 cited
Modulation of Social Cognition via Hallucinogens and “Entactogens”.

Preller, K. H., Vollenweider, F. X. · Frontiers in Psychiatry (2019)

64 cited
Effects of serotonin 2A/1A receptor stimulation on social exclusion processing

Preller, K. H., Pokorny, D., Hock, A. et al. · PNAS (2016)

172 cited
Psilocybin induces time-dependent changes in global functional connectivity: Psi-induced changes in brain connectivity

Preller, K. H., Burt, J. B., Adkinson, B. et al. · Biological Psychiatry (2020)

195 cited
An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders

Renelli, M., Fletcher, J., Tupper, K. W. et al. · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2018)

73 cited
Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

Riba, J., Mcilhenny, E. H., Valle, M. et al. · Drug Testing and Analysis (2012)

89 cited
203 cited
Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame

Sloshower, J., Guss, J., Krause, R. et al. · Journal of Contextual Behavioral Science (2020)

164 cited
Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities

Soler, J., Elices, M., Franquesa, A. et al. · Psychopharmacology (2015)

211 cited
3 cited
Patients’ accounts of increased “Connectedness” and “Acceptance” after psilocybin for treatment-resistant depression

Watts, R., Day, C. M., Krzanowski, J. et al. · Journal of Humanistic Psychology (2017)

568 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate research, and organize custom shelves.